Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

REgistry of MisOprostol 200 µg Vaginal dElivery System (REMOVE)

Trial Profile

REgistry of MisOprostol 200 µg Vaginal dElivery System (REMOVE)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Misoprostol (Primary)
  • Indications Labour induction
  • Focus Therapeutic Use
  • Acronyms REMOVE
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 15 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
    • 17 Aug 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Aug 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top